Every founder deck has an exit strategy slide. Most of them say IPO or strategic sale and leave it there. I wanted to follow one fintech from its peak private price to the day the buyer wrote the cheque, and Brex is the clearest recent case I have.
On 11 January 2022 TechCrunch reported that Brex "has raised $300 million in a Series D-2 round that ups its valuation to $12.3 billion." Greenoaks Capital and TCV co-led the round. It brought total funding to $1.2bn.
TechCrunch called it a three-year-old startup. Nine months earlier it had been valued at $7.4bn after a $425m Series D led by Tiger Global.
That was the high point. I keep it in front of me as I read. Every later number should be read against it.
Four years later the exit came. It was a sale to a bank. Capital One announced "a definitive agreement to acquire Brex, in a combination of stock and cash transaction valued at $5.15 billion."
I liked how warm the buyer sounded. Richard Fairbank, Capital One's founder and CEO, was generous about the target. "They have taken the rarest of journeys for a fintech, building a vertically integrated platform from the bottom of the tech stack to the top."
Pedro Franceschi, Brex's founder and CEO, framed it as a next chapter. "Now we get to supercharge our next chapter in partnership with the team at Capital One." The release added that he "will continue to lead Brex as part of Capital One."
The release also gave the customer base. I copied it down. Brex said "Over 25,000 of the world's best companies" run their finances on it, in more than 50 countries.
Capital One used BofA Securities and Wachtell, Lipton, Rosen & Katz. Brex used Centerview Partners as financial adviser. I see nothing unusual there. I mention it only because the adviser list is the one part of a release that nobody bothers to spin, so it is the part I trust first.
The research reason to expect a sale rather than a listing comes from Rongbing Huang, Jay Ritter and Donghang Zhang. Their review, "IPOs and SPACs: Recent Developments", appeared in the Annual Review of Financial Economics in 2023.
They describe IPOs and SPAC deals that "boomed in the United States in 2021 before collapsing in 2022". They note that private valuations reached unicorn levels "partly fueled by investments from mutual funds".
Then comes the sentence I would put on every exit strategy slide. "The most common exit for successful venture capital–backed companies, however, continues to be by merging with a larger company."
Brex fits that line exactly, and I think it fits it better than most. It reached its peak price in the 2021 private boom, the listing window shut in 2022, and the exit four years later was a merger with a larger company.
If you are writing your own exit plan, you should treat a strategic buyer as the base case. Treat the IPO as the exception. The data says so, and the Brex timeline shows what the base case can look like in practice.
The deal closed faster than the "middle of calendar year 2026" that the announcement gave. Capital One filed an 8-K on 7 April 2026. It is a short document.
It says the bank "acquired the outstanding equity of Brex for approximately $2.56 billion in cash and 10,646,306 shares of common stock". The cash amount was still "subject to customary post-closing adjustment."
The same 8-K holds a small human detail. The board gave Frank LaPrade, Capital One's chief enterprise services officer, 11,041 restricted stock units worth about $2.0m "in recognition of his contributions to completing the Transaction". I find that oddly touching. The rest of the filing is very dry.
The numbers that matter arrived three months later, in Capital One's quarterly report for the period to 30 June 2026. I went looking for the business combination note. I read all of it.
"The total consideration paid to Brex shareholders for the acquisition was approximately $4.5 billion and included $2.6 billion of cash consideration and 10.6 million shares of common stock". Those shares had "a fair value of $1.9 billion."
The table is more exact. Stock transferred was $1,891m. The cash part was $2,630m. Total purchase consideration was $4,521m.
I did the comparison twice to be sure. Against the $12.3bn of January 2022, the price at closing is 36.8% of the peak private valuation, a fall of about $7.8bn in a little over four years.
The allocation is just as telling. Assets acquired were $2,774m, including $815m of loans, $510m of developed technology and $432m of intangible assets. Liabilities were $1,322m, and they included "$1.1 billion of outstanding debt that was paid off immediately following the completion of the Brex acquisition."
That leaves net assets of $1,452m and goodwill of $3,069m. About 68% of the price is goodwill. I read that as the buyer's bet on what Brex becomes inside Capital One.
The 10-Q adds that this goodwill "is not deductible for income tax purposes", because the deal was structured as a nontaxable corporate reorganization. It was split between the Credit Card segment, $2.4bn, and Consumer Banking, $710m.
Here is where I got stuck. The announcement said $5.15bn. The accounts say $4,521m. The difference is $629m.
I had assumed the gap was the debt Capital One paid off. It is not, because adding the $1.1bn of debt to $4,521m overshoots $5.15bn by a wide margin.
The closing 8-K gives an exact share count, 10,646,306. If Capital One's share price fell between January and April, the value of that stock part would shrink. That is my best guess for most of the gap. I have not found a document that confirms it.
This has nothing to do with the price. Capital One booked $96m of integration expenses related to Brex in the second quarter, "primarily driven by salaries and associate benefits and professional services".
From the second quarter, "Domestic Card results include Brex and our legacy corporate card product." Brex stopped being a separate line in the accounts almost immediately.
Right, back to the exit itself.
I keep thinking about the timeline as a whole. It runs $12.3bn in January 2022, $5.15bn in January 2026 and $4.52bn at closing in April 2026. My guess is that most founders who raised in 2021 will see some version of that line.
The cash part alone, $2.63bn, is more than twice the $1.2bn TechCrunch said Brex had raised by January 2022. I have not checked whether Brex raised more after that date, so I would not call this a loss or a gain for any single investor.
The most important question for founders and staff is how the $4.52bn was split between preferred and common shares. I don't know, because neither filing shows the liquidation preferences. That is the gap in the public record that still bothers me, and it is the line every employee holding options would want to see.